BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China · Delayed Price · Currency is CNY 53.39
+1.49 (2.87%)
At close: Oct 24, 2025
SHA:688166 Revenue
BrightGene Bio-Medical Technology had revenue of 288.48M CNY in the quarter ending June 30, 2025, a decrease of -9.16%. This brings the company's revenue in the last twelve months to 1.16B, down -7.00% year-over-year. In the year 2024, BrightGene Bio-Medical Technology had annual revenue of 1.28B with 8.74% growth.
Revenue (ttm)
1.16B
Revenue Growth
-7.00%
P/S Ratio
19.42
Revenue / Employee
1.00M
Employees
1,151
Market Cap
22.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.28B | 103.03M | 8.74% |
| Dec 31, 2023 | 1.18B | 162.19M | 15.94% |
| Dec 31, 2022 | 1.02B | -35.08M | -3.33% |
| Dec 31, 2021 | 1.05B | 267.03M | 34.00% |
| Dec 31, 2020 | 785.38M | 282.23M | 56.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 42.62B |
| WuXi AppTec | 41.90B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |
| Shanghai Fosun Pharmaceutical (Group) | 40.12B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Jiangsu Hengrui Medicine | 30.15B |
| Zhejiang NHU Company | 22.87B |
| Aier Eye Hospital Group | 21.94B |